Eco Animal Health (GB:EAH) has released an update.
ECO Animal Health Group PLC, a growing global animal health company, is set to release its annual financial results on 15 July 2024, following a year marked by advancements in its veterinary product portfolio and R&D pipeline. The company, known for its flagship antibiotic and vaccine products for livestock, will also facilitate a virtual analyst briefing led by CEO David Hallas and CFO Christopher Wilks to discuss the results. ECO operates worldwide, with more than 200 employees and a lead product, Aivlosin®, targeting respiratory and intestinal diseases in pigs and poultry.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.
